Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 10,666 | 4,969 | 8,406 | 6,152 | 4,086 |
| Operating Income | -10,666 | -4,969 | -8,406 | -6,152 | -4,086 |
| Interest Expense | -47 | -91 | 450 | 437 | 430 |
| Other Income | 873 | 980 | 961 | 1,572 | 97 |
| Pre-tax Income | -9,747 | -3,898 | -7,895 | -5,018 | -4,420 |
| Income Tax | 0 | N/A | 8 | 2 | N/A |
| Net Income Continuous | -9,747 | -3,898 | -7,903 | -5,020 | -4,420 |
| Net Income | $-9,747 | $-3,898 | $-7,903 | $-5,020 | $-4,420 |
| EPS Basic Total Ops | -0.25 | -0.10 | -0.20 | -0.18 | -0.03 |
| EPS Basic Continuous Ops | -0.24 | -0.10 | -0.20 | -0.18 | -0.04 |
| EPS Diluted Total Ops | -0.25 | -0.10 | -0.20 | -0.18 | -0.03 |
| EPS Diluted Continuous Ops | -0.24 | -0.10 | -0.20 | -0.18 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.22 | -0.20 | N/A | N/A |
| EBITDA(a) | $-10,491 | $-4,791 | $-8,126 | $-5,888 | $-3,830 |